Published in Gene Therapy Weekly, July 1st, 2004
The amount of the award is $993,463.
Apoptosis is the genetically programmed process of precise, predictable cell suicide. It occurs as a normal physiological process for removing unnecessary cells throughout the life of an organism.
Inappropriate apoptosis has been shown to be the cause of many diseases. Development of agents that modulate apoptosis is a major focus of biopharmaceutical research. The ability to manipulate apoptosis could permit...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.